Soligenix, Inc. (SNGX) announced a publication describing the preclinical efficacy of CiVax, a thermostabilized subunit vaccine against SARS-CoV-2. In collaboration with Axel Lehrer, Professor at the Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawai?i at Manoa, the manuscript has been published in COVID.
Using custom-developed immunoassays, the combination of a primary adenovirus vaccine coupled with a CiVax booster was shown to induce broader protection against COVID-19 variants in non-human primates than a 2-shot mRNA series in humans.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.